Approval · Notice of Compliance 17035 · 2015
FERAHEME: Notice of Compliance 17035
Issued June 25, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17035
- Date
- June 25, 2015
- Company
- Amag Pharmaceuticals IncWaltham, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug idnetification number
- Therapeutic class
- Hematinic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERAHEME | 02377217 | Cancelled Post Market |
Medicinal ingredients
- FERUMOXYTOL 30 MG per ML